← Back to Search

Endovascular Graft

Endovascular Graft + Covered Stent for Abdominal Aortic Aneurysm

N/A
Waitlist Available
Led By Mark A Farber, MD
Research Sponsored by Cook Research Incorporated
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Pararenal or juxtarenal AAA ≥5.0 cm in diameter or 2 times the normal aortic diameter
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial is testing a new endovascular graft in combination with a covered stent to treat abdominal aortic aneurysms. The goal is to see if this new treatment is safe and effective.

Who is the study for?
This trial is for adults with a specific type of bulging artery in their abdomen (abdominal aortic aneurysm) that's at risk of bursting. It's not for those under 18, pregnant or planning pregnancy within five years, unable to consent, unwilling to follow the study plan, involved in another study recently, or expected to live less than two more years.Check my eligibility
What is being tested?
The Zenith® p-Branch® Pivotal Study tests the safety and effectiveness of the Zenith® p-Branch® graft combined with Atrium iCAST™ covered stents in treating abdominal aortic aneurysms. The FDA has approved this trial.See study design
What are the potential side effects?
While specific side effects are not listed here, endovascular procedures like this can generally cause complications such as bleeding, infection at the incision site, blood vessel damage, and reactions to anesthesia.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My abdominal aorta is enlarged to 5.0 cm or twice its normal size.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Treatment Success Proportion

Trial Design

1Treatment groups
Experimental Treatment
Group I: EndovascularExperimental Treatment1 Intervention
Endovascular treatment using the Zenith® p-Branch® in combination with the Atrium iCAST™ covered stents

Find a Location

Who is running the clinical trial?

Cook Research IncorporatedLead Sponsor
30 Previous Clinical Trials
253,973 Total Patients Enrolled
Mark A Farber, MDPrincipal InvestigatorUniversity of North Carolina
2 Previous Clinical Trials
675 Total Patients Enrolled

Media Library

Zenith® p-Branch® Endovascular Graft (Endovascular Graft) Clinical Trial Eligibility Overview. Trial Name: NCT02396199 — N/A
Abdominal Aortic Aneurysm Research Study Groups: Endovascular
Zenith® p-Branch® Endovascular Graft (Endovascular Graft) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02396199 — N/A
Abdominal Aortic Aneurysm Clinical Trial 2023: Zenith® p-Branch® Endovascular Graft Highlights & Side Effects. Trial Name: NCT02396199 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the geographic extent of this research experiment?

"Currently, 27 different medical sites are recruiting patients for this trial. Notable cities include Atlanta, New york and Stanford. To diminish the need to travel excessively far, it is recommended that individuals seek out the closest location they can access if they decide to participate."

Answered by AI

Are there any opportunities for individuals to join this experiment?

"Information contained on clinicaltrials.gov suggests that recruitment for this study has ceased, with the original posting being made in August of 2015 and an updated version released October 3rd 2022. Despite its dormancy, there are 153 other trials actively seeking volunteers at present."

Answered by AI
~8 spots leftby Apr 2025